Chempass Company
ChemPass was founded to develop AI technologies and software for the design of novel small organic molecules and scaffolds. ChemPass' technologies utilize synthetic artificial intelligence for template design, in silico reaction planning and evaluation, a chemistry know-how database and several other custom solutions.
%20.jpg)
Funding Status:
Seed
Industry:
Drug Discovery
Number Of Exists:
N/A
Technology:
Drug Design
Founded Date:
2016
Investor Type:
N/A
Headquarters:
Budapest, Budapest, Hungary
Employee Number:
Undisclosed
Investment Stage:
N/A